Biocon Ltd. Nine-Monthly Results: Standalone & Consolidated Reports

Nine Monthly Results

Results Snapshot

Figures in Cr

Consolidate Nine Monthly Results

Dec'25

Dec'24

Dec'23

Dec'22

Dec'21

Dec'20

Dec'19

Net Sales

12,410.40

10,844.70

10,838.60

7,400.30

5,775.20

5,294.60

4,774.30

Other Operating Income

0.00

Total Operating income

12,410.40

10,844.70

10,838.60

7,400.30

5,775.20

5,294.60

4,774.30

Raw Material Cost

3,918.80

3,162.50

3,594.10

2,776.80

2,066.10

1,811.10

1,615.40

Purchase of Finished goods

1,140.00

543.10

682.80

123.70

111.50

67.90

63.50

(Increase) / Decrease In Stocks

-767.40

19.00

-708.50

-466.20

-287.50

-220.20

-210.00

Employee Cost

2,595.90

2,333.30

1,922.50

1,611.70

1,409.80

1,288.90

1,070.40

Power Cost

0.00

Manufacturing Expenses

0.00

Selling and Distribution Expenses

0.00

Other Expenses

3,105.30

2,729.20

2,964.90

1,839.90

1,152.00

1,142.70

950.50

Total Expenditure (Excl Depreciation)

9,992.60

8,787.10

8,455.80

5,885.90

4,451.90

4,090.40

3,489.80

Operating Profit (PBDIT) excl Other Income

2,417.80

2,057.60

2,382.80

1,514.40

1,323.30

1,204.20

1,284.50

Other Income

290.00

1,201.80

816.90

221.00

200.40

61.70

98.30

Operating Profit (PBDIT)

2,707.80

3,259.40

3,199.70

1,735.40

1,523.70

1,265.90

1,382.80

Interest

758.80

685.00

747.40

170.20

57.10

23.80

48.10

Exceptional Items

-305.30

76.10

-2.80

-288.40

-70.10

0.00

50.20

Gross Profit (PBDT)

1,643.70

2,650.50

2,449.50

1,276.80

1,396.50

1,242.10

1,402.20

Depreciation

1,443.30

1,250.70

1,161.80

749.40

602.00

530.80

399.80

Profit Before Tax

200.40

1,399.80

1,263.60

471.80

747.30

711.30

1,002.40

Tax

30.20

429.80

131.30

172.00

152.90

152.10

270.10

Provisions and contingencies

0.00

Profit After Tax

170.20

970.00

1,156.40

355.40

641.60

559.20

732.30

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

-0.80

-17.30

Net Profit

170.20

970.00

1,156.40

355.40

641.60

558.40

715.00

Share in Profit of Associates

0.00

-81.50

-126.90

-153.90

-8.60

-3.20

Minority Interest

-301.70

-189.20

-1.30

-36.80

-12.90

-26.50

-32.00

Other related items

0.00

Consolidated Net Profit

259.70

668.80

887.00

149.50

409.80

487.30

624.80

Equity Capital

668.50

600.30

600.00

Face Value

5.0

Reserves

0.00

Diluted Earnings per share

1.07

0.21

5.51

-0.35

1.56

1.4

1.71

Operating Profit Margin (Excl OI)

19.48%

18.97%

21.98%

20.46%

22.91%

22.74%

26.9%

Gross Profit Margin

13.24%

24.44%

22.6%

17.25%

24.18%

23.46%

29.37%

PAT Margin

1.37%

8.94%

10.67%

4.8%

11.11%

10.56%

15.34%

Public Share Holdings (%)

0.0%

Pledged Promotor Holding (%)

0.0%

Nine Monthly Analysis Highlights

Net Sales

YoY Growth in nine months ended Dec 2025 is 14.44% vs 0.06% in Dec 2024

Consolidate Net Profit

YoY Growth in nine months ended Dec 2025 is -61.17% vs -24.60% in Dec 2024

Operating Profit (PBDIT) excl Other Income

YoY Growth in nine months ended Dec 2025 is 17.51% vs -13.65% in Dec 2024

Interest

YoY Growth in nine months ended Dec 2025 is 10.77% vs -8.35% in Dec 2024

Operating Profit Margin (Excl OI)

YoY Growth in nine months ended Dec 2025 has improved from Dec 2024

Compare Nine Monthly Results Of Biocon With

Select Peers

Figures in Cr

Consolidate Nine Monthly Results

Change(INR)

Change(%)

Net Sales

12,410.40

11,108.95

1,301.45

11.72%

Other Operating Income

0.00

Total Operating income

12,410.40

11,108.95

1,301.45

11.72%

Raw Material Cost

3,918.80

2,670.45

1,248.35

46.75%

Purchase of Finished goods

1,140.00

1,196.73

-56.73

-4.74%

(Increase) / Decrease In Stocks

-767.40

-22.28

-745.12

-3,344.34%

Employee Cost

2,595.90

2,125.01

470.89

22.16%

Power Cost

0.00

Manufacturing Expenses

0.00

Selling and Distribution Expenses

0.00

Other Expenses

3,105.30

2,651.22

454.08

17.13%

Total Expenditure (Excl Depreciation)

9,992.60

8,621.13

1,371.47

15.91%

Operating Profit (PBDIT) excl Other Income

2,417.80

2,487.82

-70.02

-2.81%

Other Income

290.00

383.28

-93.28

-24.34%

Operating Profit (PBDIT)

2,707.80

2,871.10

-163.30

-5.69%

Interest

758.80

106.90

651.90

609.82%

Exceptional Items

-305.30

-39.86

-265.44

-665.93%

Gross Profit (PBDT)

1,643.70

2,724.34

-1,080.64

-39.67%

Depreciation

1,443.30

276.30

1,167.00

422.37%

Profit Before Tax

200.40

2,448.04

-2,247.64

-91.81%

Tax

30.20

346.59

-316.39

-91.29%

Provisions and contingencies

0.00

Profit After Tax

170.20

2,101.45

-1,931.25

-91.90%

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

170.20

2,101.45

-1,931.25

-91.90%

Share in Profit of Associates

0.00

-1.40

1.40

100.00%

Minority Interest

-301.70

-0.69

-301.01

-43,624.64%

Other related items

0.00

Consolidated Net Profit

259.70

2,065.34

-1,805.64

-87.43%

Equity Capital

668.50

23.91

644.59

2,695.90%

Face Value

5.00

2.00

0.00

Reserves

0.00

Gross Profit Margin

13.24%

24.52%

0.00

-11.28%

PAT Margin

1.37%

18.92%

0.00

-17.55%

Public Share Holdings (%)

0.00%

0.00

0.00%

Pledged Promotor Holding (%)

0.00%

0.00

0.00%

Nine Monthly - Net Sales

Net Sales 12,410.40 Cr

in Dec 2025

Figures in Cr

YoY Growth in nine months ended Dec 2025 is 14.44% vs 0.06% in Dec 2024

Nine Monthly - Consolidate Net Profit

Consolidate Net Profit 259.70 Cr

in Dec 2025

Figures in Cr

YoY Growth in nine months ended Dec 2025 is -61.17% vs -24.60% in Dec 2024

Nine Monthly - Operating Profit (PBDIT)

Operating Profit (PBDIT) 2,417.80 Cr

in Dec 2025

Figures in Cr

YoY Growth in nine months ended Dec 2025 is 17.51% vs -13.65% in Dec 2024

Nine Monthly - Interest

Interest 758.80 Cr

in Dec 2025

Figures in Cr

YoY Growth in nine months ended Dec 2025 is 10.77% vs -8.35% in Dec 2024

Nine Monthly - Operating Profit Margin (Excl OI)

Operating Profit Margin (Excl OI) 19.48%

in Dec 2025

Figures in %

YoY Growth in nine months ended Dec 2025 has improved from Dec 2024